DE3878313D1 - Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. - Google Patents

Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.

Info

Publication number
DE3878313D1
DE3878313D1 DE8888108373T DE3878313T DE3878313D1 DE 3878313 D1 DE3878313 D1 DE 3878313D1 DE 8888108373 T DE8888108373 T DE 8888108373T DE 3878313 T DE3878313 T DE 3878313T DE 3878313 D1 DE3878313 D1 DE 3878313D1
Authority
DE
Germany
Prior art keywords
bile
wallstones
treatment
disorders
taurohyodeoxycholic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888108373T
Other languages
English (en)
Other versions
DE3878313T2 (de
Inventor
Mario Angelico
Simos Contos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enosys SA
Original Assignee
Enosys SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enosys SA filed Critical Enosys SA
Application granted granted Critical
Publication of DE3878313D1 publication Critical patent/DE3878313D1/de
Publication of DE3878313T2 publication Critical patent/DE3878313T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8888108373T 1987-06-03 1988-05-26 Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen. Expired - Fee Related DE3878313T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8720771A IT1212141B (it) 1987-06-03 1987-06-03 Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.

Publications (2)

Publication Number Publication Date
DE3878313D1 true DE3878313D1 (de) 1993-03-25
DE3878313T2 DE3878313T2 (de) 1993-05-27

Family

ID=11171828

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888108373T Expired - Fee Related DE3878313T2 (de) 1987-06-03 1988-05-26 Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.

Country Status (7)

Country Link
US (1) US4917898A (de)
EP (1) EP0293751B1 (de)
JP (1) JP2649699B2 (de)
AT (1) ATE85523T1 (de)
DE (1) DE3878313T2 (de)
ES (1) ES2045009T3 (de)
IT (1) IT1212141B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
IT1245891B (it) 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche a rilascio controllato per uso orale gastroresistenti contenenti acidi biliari e loro sali.
CH680704A5 (de) * 1991-05-15 1992-10-30 Medichemie Ag
IT1249686B (it) * 1991-07-22 1995-03-09 Boniscontro E Gazzone S R L Preparazioni farmaceutiche orali, a base di acidi biliari, a cessione protratta e controllata con le quali e' possibile adottare una sola somministrazione giornaliera
IT1257793B (it) * 1992-05-18 1996-02-13 Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
GR920100437A (el) * 1992-10-12 1994-06-30 Boniscontro E Gazzone S R L Φαρμακευτικά σκευάσματα βραδείας απελευ?έρωσης χορηγούμενα από του στόματος και περιέχοντα χολικά οξέα.
ES2059262B1 (es) * 1992-10-13 1995-10-01 Boniscontro E Gazzone S R L Composiciones farmaceuticas orales de liberacion sostenida conteniendo acidos biliares.
DE29717252U1 (de) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
EP1189922A4 (de) * 1999-04-30 2002-08-14 Arch Dev Corp Steroid derivate
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
AU2003228485A1 (en) * 2002-04-12 2003-10-27 The University Of Chicago Farnesoid x-activated receptor agonists
KR20030097067A (ko) * 2002-06-19 2003-12-31 현대자동차주식회사 자동차의 델터 커버
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US20060276812A1 (en) * 2005-04-04 2006-12-07 Hill James W Dynamic reinforcement of the lower esophageal sphincter
US8829213B2 (en) * 2009-07-29 2014-09-09 The University Of Chicago Liver X receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IT1196377B (it) * 1984-12-21 1988-11-16 Lehner Ag Derivati di acidi biliari,procedimento per la loro preparazione e relative composizioni farmaceutiche
JPS61158995A (ja) * 1984-12-28 1986-07-18 Takara Shironaga 脂肪肝，胆石，胃粘膜障害発生の予防薬または治療薬

Also Published As

Publication number Publication date
IT8720771A0 (it) 1987-06-03
IT1212141B (it) 1989-11-08
JPS6463522A (en) 1989-03-09
EP0293751A2 (de) 1988-12-07
JP2649699B2 (ja) 1997-09-03
EP0293751B1 (de) 1993-02-10
ATE85523T1 (de) 1993-02-15
DE3878313T2 (de) 1993-05-27
ES2045009T3 (es) 1994-01-16
EP0293751A3 (en) 1990-07-25
US4917898A (en) 1990-04-17

Similar Documents

Publication Publication Date Title
DE3878313D1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
GR79989B (de)
SE7903186L (sv) Cerebralverksamt medel
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
HUT50148A (en) Process for production of derivatives of antiflammation furanon and medical compositions containing them
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
NO913685L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE69022027D1 (de) 2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.
DE69313534D1 (de) Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee